Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Fontaine, Christel*" or (type exact bookEditor and editor="Fontaine, Christel*")

Add to list
- Conference Paper
- C3
A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients

Odrade Gondry, Catarina Xavier, Johannes Heemskerk, Laurens Albert J Raes, Jens Debacker (UGent) , Frank De Geeter, Christel Fontaine, Marian Vanhoeij, SANDRINE ASPESLAGH (UGent) , Sofie Joris, et al.

(2023) EMIM 2023, European Molecular Imaging Meeting, Abstracts.
Add to list
- Journal Article
- A1
- open access
A randomised wait-list controlled trial to evaluate Emotional Freedom Techniques for self-reported cancer-related cognitive impairment in cancer survivors (EMOTICON)

Laura Tack (UGent) , Tessa Lefebvre, Michelle Lycke, Christine Langenaeken, Christel Fontaine, Marleen Borms, Marianne Hanssens, Christel Knops, Kathleen Meryck, Tom Boterberg (UGent) , et al.

(2021) ECLINICALMEDICINE. 39.
Add to list
- Journal Article
- A1
- open access
Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19 : a nationwide, population-based analysis

Evandro de Azambuja, Mariana Brandao, Hans Wildiers, Annouschka Laenen, Sandrine Aspeslagh, Christel Fontaine, Joelle Collignon, Willem Lybaert, Jolanda Verheezen, Annemie Rutten, et al.

(2020) ESMO OPEN. 5(5).
Add to list
Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy

Jean-Pascal Henry Machiels, Aline Van Maanen, Jean-Marie Vandenbulcke, Bertrand Filleul, Emmanuel Seront, Stéphanie Henry, Lionel D'Hondt, Christophe Lonchay, Stéphane Holbrechts, Petra Boegner, et al.

(2016) ONCOLOGIST. 21(12). p.1416-e17
Add to list
- Journal Article
- A1
- open access
Phase I study of 68Ga-HER2-nanobody for PET/CT assessment of HER2 expression in breast carcinoma

Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Chloé Ackaert, Marian Vanhoeij, Francois Duhoux, Thierry Gevaert, Philippe Simon, et al.

(2016) JOURNAL OF NUCLEAR MEDICINE. 57(1). p.27-33
Add to list
Savene® (dexrazoxane) use in clinical practice

Christel Fontaine, Lucien Noens (UGent) , Pascal Pierre and Jacques de Grève

(2012) SUPPORTIVE CARE IN CANCER. 20(5). p.1109-1112
Add to list
- Journal Article
- A1
Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases

Bart Neyns, Maridi Aerts, Yves Van Nieuwenhove (UGent) , Christel Fontaine, Lore De Coster, Dennis Schallier, Jacques Vanderauwera, Floris De Munck, Frederik Vandenbroucke, Hendrik Everaert, et al.

(2008) ANTICANCER RESEARCH. 28(4C). p.2459-2467
Add to list
- Conference Paper
- C3
A feasibility study on hepatic arterial infusion (HAI) of oxaliplatin followed by I-folinic acid modulated continuous HAI of 5-fluorouracil as second line chemotherapy for stage IV colorectal cancer limited to the liver

Bart Neyns, Yves Van Nieuwenhove (UGent) , Christel Fontaine, Joanna Vermeij, Erica Sermijn, Dennis Schallier, Johan De Mey, Frederik Vandenbroucke, Georges Delvaux and Jacques De Greve

(2004) ANNALS OF ONCOLOGY. 15(suppl. 3). p.97-97

Academic Bibliography

A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients

A randomised wait-list controlled trial to evaluate Emotional Freedom Techniques for self-reported cancer-related cognitive impairment in cancer survivors (EMOTICON)

Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19 : a nationwide, population-based analysis

Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy

Phase I study of 68Ga-HER2-nanobody for PET/CT assessment of HER2 expression in breast carcinoma

Savene® (dexrazoxane) use in clinical practice

Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases

A feasibility study on hepatic arterial infusion (HAI) of oxaliplatin followed by I-folinic acid modulated continuous HAI of 5-fluorouracil as second line chemotherapy for stage IV colorectal cancer limited to the liver

Contents

Support

Contact